78,501 Shares in Azenta, Inc. (NASDAQ:AZTA) Purchased by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC acquired a new position in shares of Azenta, Inc. (NASDAQ:AZTA) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 78,501 shares of the company’s stock, valued at approximately $3,925,000. Susquehanna Fundamental Investments LLC owned 0.17% of Azenta at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Virtu Financial LLC acquired a new stake in shares of Azenta during the third quarter worth approximately $352,000. Nordea Investment Management AB boosted its stake in shares of Azenta by 5.7% during the 4th quarter. Nordea Investment Management AB now owns 84,804 shares of the company’s stock valued at $4,326,000 after buying an additional 4,606 shares during the period. Oak Thistle LLC purchased a new position in shares of Azenta during the 4th quarter valued at $927,000. Assenagon Asset Management S.A. purchased a new position in shares of Azenta during the 4th quarter valued at $200,000. Finally, Ballentine Partners LLC increased its stake in shares of Azenta by 2.0% in the fourth quarter. Ballentine Partners LLC now owns 20,340 shares of the company’s stock worth $1,017,000 after acquiring an additional 404 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Price Performance

Shares of NASDAQ:AZTA opened at $27.02 on Tuesday. The stock has a market capitalization of $1.23 billion, a P/E ratio of -9.07 and a beta of 1.66. The business has a 50-day moving average of $34.66 and a two-hundred day moving average of $43.11. Azenta, Inc. has a fifty-two week low of $24.06 and a fifty-two week high of $63.58.

Azenta (NASDAQ:AZTA) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, research analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on AZTA. Evercore ISI lifted their price objective on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Stephens reiterated an “overweight” rating and set a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd. TD Cowen upgraded Azenta to a “hold” rating in a report on Thursday, February 27th. Finally, Needham & Company LLC lifted their target price on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research note on Thursday, February 6th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.